 |
Our Astaxanthin Products
|
AstaREAL
AstaReal is the Fuji brand of astaxanthin extracted from haematococcus
pluvialis by a solvent free supercritical CO2 extraction process.
Contains esterified
astaxanthin complex including other carotenoids: Lutein, Canthaxanthin and
 -carotene.
AstaREAL L10 - is a high
quality astaxanthin oil extract, which contains 10% natural astaxanthin
complex. Ideal for blending and use in softgel capsules.
AstaREAL
P2 AF - is a high quality astaxanthin
powdered extract, which contains 2% natural astaxanthin complex
and has been designed to fill
multiple roles to better serve the dietary supplement
industry. In addition to being an all vegetable formula,
AstaREAL P2 AF is directly compressible, water dispersible, very
stable, flowable and free of the major allergens as identified
by the FDA. Its application areas include two piece hard
shells, tablets, powdered drinks, bars and more.
|
Application Areas |
- Antioxidant
- Increased muscle endurance and reduced muscle
damage**
- Reduced eye fatigue and improved visual acuity**
- Wrinkle reduction by internal supplementation**
- Immunomodulation**
- Reduction of hyper pigmentation
- Cytokine regulation**
- Gastric Health**
** Fuji patents / patents pending
|
| Product Index |
|
Nutraceutical
Astaxanthin
Tocotrienol
Pharmaceutical
Fujicalin
Neusilin
F-Melt
Personal Care
Astaxanthin
Tocotrienol
Neusilin |
|
|
HomeFuji NewsletterStudy ReferencesAssay MethodPatents
Patents
Fuji astaxanthin Patents
for human application
| No. 6,245,818 |
Increased physical endurance / reduced muscle damage |
| No. 6,773,708 |
Immunomodulation - autoimmune diseases and chronic viral
and intracellular bacterial infections |
| No. 6,262,316 |
Gastric health - reduces infection/inflammation of H. pylori |
| No. 6,410,602 |
Fertility - method of increasing the production and improving
the quality of semen |
| No. 7,078,040 |
Cytokine regulation - inhibiting the expression of inflammatory
cytokines and chemokines |
| No. 6,923,967 |
Alleviates dyspeptic symptoms |
| No. 6,335,015 |
Prophylactic Treatment for mastitis |
Patent Pending
|
Reduced eye fatigue / improved visual acuity |
| Patent Pending |
Weight Loss - BMI reduction |
| Patent Pending |
Gene expression modulator - suppression of development of
diabetic nephropathy |
|
|
|
